Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $2.11M | ﹤0.01% |
190,518
+24,617
| +15% | +$214K |
|
|
SBBX
2927
DELISTED
SB One Bancorp Common Stock
SBBX
| $2.11M | ﹤0.01% |
84,556
+1,343
| +2% | +$31K |
|
|
AMRS
2928
DELISTED
Amyris Inc.
AMRS
| $2.1M | ﹤0.01% |
681,392
+80,648
| +13% | +$299K |
|
|
CASI
2929
DELISTED
CASI Pharmaceuticals
CASI
| $2.1M | ﹤0.01% |
68,105
+462
| +0.7% | +$15K |
|
2930
Uranium Energy
UEC
$5.62B
| $2.1M | ﹤0.01% |
2,283,397
+50,157
| +2% | +$48.6K |
|
|
UN
2931
DELISTED
Unilever NV New York Registry Shares
UN
| $2.1M | ﹤0.01% |
36,512
+5,634
| +18% | +$333K |
|
2932
Peoples Bancorp of North Carolina
PEBK
$239M
| $2.09M | ﹤0.01% |
63,772
+317
| +0.5% | +$9.67K |
|
|
LOVE
2933
LoveSac
LOVE
$253M
| $2.09M | ﹤0.01% |
130,256
+14,342
| +12% | +$224K |
|
2934
Bassett Furniture
BSET
$171M
| $2.08M | ﹤0.01% |
124,899
-8,459
| -6% | -$131K |
|
2935
eGain
EGAN
$200M
| $2.08M | ﹤0.01% |
262,886
+9,293
| +4% | +$71.9K |
|
2936
Pulse Biosciences
PLSE
$3.09B
| $2.08M | ﹤0.01% |
155,193
+2,283
| +1% | +$32.5K |
|
|
CSLT
2937
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.08M | ﹤0.01% |
1,562,629
+388,579
| +33% | +$542K |
|
2938
Chemung Financial Corp
CHMG
$401M
| $2.07M | ﹤0.01% |
48,679
+6,755
| +16% | +$296K |
|
|
IIF
2939
Morgan Stanley India Investment Fund
IIF
$220M
| $2.07M | ﹤0.01% |
103,882
-89,042
| -46% | -$1.72M |
|
2940
Princeton Bancorp
BPRN
$295M
| $2.06M | ﹤0.01% |
65,581
+668
| +1% | +$19.7K |
|
|
REV
2941
DELISTED
Revlon, Inc.
REV
| $2.06M | ﹤0.01% |
96,382
-6,451
| -6% | -$155K |
|
2942
DHI Group
DHX
$166M
| $2.06M | ﹤0.01% |
685,330
-10,081
| -1% | -$34.3K |
|
2943
Fastly Inc
FSLY
$4.54B
| $2.06M | ﹤0.01% |
102,654
+4,060
| +4% | +$85.6K |
|
2944
NI Holdings
NODK
$314M
| $2.06M | ﹤0.01% |
119,759
+275
| +0.2% | +$4.71K |
|
|
EVBN
2945
DELISTED
Evans Bancorp Inc
EVBN
| $2.06M | ﹤0.01% |
51,353
+4,244
| +9% | +$165K |
|
|
ID
2946
DELISTED
PARTS iD, Inc.
ID
| $2.05M | ﹤0.01% |
200,000
| – | – |
|
2947
Stagwell
STGW
$2.29B
| $2.05M | ﹤0.01% |
738,270
+43,089
| +6% | +$116K |
|
2948
First Northwest Bancorp
FNWB
$107M
| $2.05M | ﹤0.01% |
112,999
+1,102
| +1% | +$19.3K |
|
2949
American Superconductor
AMSC
$1.56B
| $2.05M | ﹤0.01% |
260,719
+6,967
| +3% | +$56.1K |
|
2950
KVH Industries
KVHI
$142M
| $2.04M | ﹤0.01% |
183,439
+5,937
| +3% | +$63K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.